From J D Faccinetti – co-founder – If you are currently taking injections of Octreotide or Lanreotide for the maintenance treatment of acromegaly you might be interested in this new clinical study. The materials and links below will provide information for you and your physician.
The MPOWERED clinical study is being conducted to compare the safety and effectiveness of an investigational new drug product, oral octreotide capsules, to existing injectable medications (octreotide and lanreotide) for the maintenance treatment of acromegaly.
For more information for patients and families, physicians, inclusion and exclusion criteria, contact information and FAQ’s visit the MPOWERED website, or you can download the brochures by clicking on the visuals
The study is being conducted by Chiasma, Inc. Chiasma, Inc. is a biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.
© 2016, Pituitary World News. All rights reserved.